-+ 0.00%
-+ 0.00%
-+ 0.00%

Barrington Research Maintains Outperform on LeMaitre Vascular, Raises Price Target to $120

Benzinga·05/06/2026 23:20:03
Listen to the news
Barrington Research analyst Michael Petusky maintains LeMaitre Vascular (NASDAQ:LMAT) with a Outperform and raises the price target from $105 to $120.